Full-Time

Senior Data Scientist/Data Engineer

Posted on 6/16/2025

Nomic

Nomic

51-200 employees

high-throughput proteomics platform employing nELISA

No salary listed

Montreal, QC, Canada

In Person

Category
Data & Analytics (2)
,
Required Skills
Data Analysis
Requirements
  • Graduate Degree - or equivalent experience in industry - in bioengineering or a related quantitative field of study in the biosciences, with a focus on biosensors, quantitative fluorescence data, or similar.
  • 3+ years of experience specifically with analyzing bioscience data and developing improved data processing algorithms.
  • 2+ years software engineering/development experience - you must be comfortable standing up new toolsets for non-programming users, and coding in a collaborative environment together with experienced data and software engineers.
  • Statistical skills including bayesian statistics, sampling methods, mixed models, and experience applying other statistical concepts.
  • Strong past experience working collaboratively on data science problems with wet lab scientists, ideally in a startup or equivalent fast paced environment.
Responsibilities
  • Designing, building, iteratively improving, and fully automating the data pipelines and algorithms we use for processing raw flow cytometry data from our highly multiplexed bead-based assays into quantitative protein measurements. This will be done in close collaboration with your Data Engineering, Software Engineering, and Lab R&D teammates.
  • You will leverage your fundamental knowledge of biosensors, fluorescence data, and bioengineering R&D to act as an expert for the interpretation, and analysis of, nELISA experimental data coming from R&D and day-to-day Lab Operations, connecting the fundamentals of the science to the specific features or anomalies of the data.
  • You will also support R&D and Lab Operations teams through developing additional data support features and algorithms to support the growth of Nomic going forward. This will include any new data analysis pipelines to analyze nELISA data, including QC data from our daily manufacturing and profiling operations.
  • This role will involve substantial communication, teamwork, and attention to detail, especially when identifying and troubleshooting issues related to nELISA data and ensuring we build the right tools, and the right abstractions.
  • When tooling does not yet exist, you will be responsible for analyzing nELISA data using our suite of decoding and analysis tools, as well as leveraging your technical and bioscience domain expertise to develop new data analysis pipelines when needed.
  • Moreover, you will be relied on to support our R&D and Lab Operations teams with guidance on experimental design and analysis when needed, drawing on your previous experience doing the same.
Desired Qualifications
  • Understanding of the fundamentals of life science tools, technologies and lab methods. In particular you would be an expert on multiple of: immunoassays, nucleic acid amplification, DNA nanoarchitecture and design, separation-based techniques for biological samples and compounds, biophysics / fluorescence, and signal processing.
  • First hand experience optimizing (alone or in a team): surface chemistry (passivation, functionalization, regeneration), DNA-based circuits and DNA biosensor designs, fluorophores/fluorescence and FRET, antibody-antigen interactions and ligand binding, or similar domains.
  • Excellent communication skills (written, verbal, and in a codebase) and an independent problem solver.
  • Fluency in English is required as our customers and vendors are primarily located in the USA. In addition, this position will interact with our team members within our USA entity.

Nplex Biosciences develops proteomics tools using nanotechnology, including the nELISA platform for high-throughput protein measurement. The platform uses DNA nanotechnology to identify proteins on micron-sized beads, enabling miniaturized, highly parallel immunoassays. It differentiates itself by combining DNA-based protein identification with bead-based assays and a scalable, cost-efficient workflow that lowers the cost of antibody-based proteomics. Its goal is to provide a reliable, scalable proteomics platform that supports drug discovery, biomarker discovery, and personalized medicine.

Company Size

51-200

Company Stage

Series B

Total Funding

$60.1M

Headquarters

Montreal, Canada

Founded

2017

Simplify Jobs

Simplify's Take

What believers are saying

  • Omni 1000 democratizes proteome-wide profiling for drug discovery and biomarker validation.[5]
  • $42M Series B September 2024 funds commercial expansion amid rising demand.[5]
  • Context-specific ~300-protein panels enable targeted discovery without multiplexing limitations.[2]

What critics are saying

  • Olink's Explore HT delivers 6000+ proteins, capturing larger pharma budgets.[1]
  • SomaScan's 11,000-protein aptamer technology erodes biomarker discovery market share.[1]
  • Post-Series B cash burn exceeds revenue as manufacturing scales in 2026.[1]

What makes Nomic unique

  • nELISA technology enables 1000-plex protein measurement at $50 per sample affordably.[5]
  • DNA-barcoded beads decode protein identity on standard flow cytometers seamlessly.[3]
  • End-to-end service model compatible with existing lab workflows and automation.[4]

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

1%

1 year growth

4%

2 year growth

1%
Yahoo Finance
Sep 19th, 2024
Nomic® Secures $42M in Oversubscribed Series B to Expand Access to Protein Profiling

MONTREAL, September 17, 2024--Nomic Bio ("Nomic"), the Protein Profiling company, today announces the completion of an oversubscribed $42 million Series B funding round. The fresh capital will enable Nomic to accelerate the expansion of its commercial operations, further invest in advancing its state-of-the-art protein profiling platform, and broaden its transformative offerings to meet growing demand.

BetaKit
Mar 18th, 2020
11 Canadian companies in Y Combinator’s Winter 2020 Demo Day

This week, Y Combinator (YC) held its Winter 2020 Demo Day, the 30th for the Silicon Valley incubator. To minimize health concerns during the COVID-19 outbreak, YC opted to host the demo day online. For this cohort, 16 Canadian startups participated.

TechCrunch
Mar 17th, 2020
All the companies from Y Combinator’s W20 Demo Day, Part IV: Healthcare, Biotech, Fintech and Nonprofits

Y Combinator’s Demo Day was a bit different this time around.

INACTIVE